Pain Management in Cancer Patients Using a Mobile Application (ePAL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02069743|
Recruitment Status : Completed
First Posted : February 24, 2014
Last Update Posted : June 27, 2022
|Condition or disease||Intervention/treatment||Phase|
|Cancer||Other: ePAL Mobile Application||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||110 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Pain Management in Cancer Patients Using a Mobile Application|
|Actual Study Start Date :||February 2014|
|Actual Primary Completion Date :||August 2018|
|Actual Study Completion Date :||September 2020|
The intervention group will use the study's mobile application during the 8-week study.
Other: ePAL Mobile Application
A mobile application designed to help cancer patients better self-manage cancer pain.
Other Name: ePAL
No Intervention: Control
The control group will not use the study's mobile application during the study.
- Pain symptoms using the Brief Pain Inventory [ Time Frame: up to 8 weeks ]The primary aim is to assess the effect of a tailored, multi-dimensional mobile-based intervention on the intensity of cancer pain in cancer patients with moderate to severe pain.
- Pain related hospitalization from the Electronic Health Record [ Time Frame: up to 8 weeks ]
- In-patient and out-patient hospital visits
- Urgent non-scheduled clinic visits for pain crisis
- Patient-related barriers to pain management using the Barriers Questionnaire-II [ Time Frame: up to 8 weeks ]compared patient-related barriers to pain management using the Barriers Questionnaire-II (BQ-II)
- Engagement as tracked by the app [ Time Frame: up to 8 weeks ]Pattern of patient engagement with the study's mobile application
- Anxiety symptoms using the Generalized Anxiety Disorder (GAD-7) [ Time Frame: up to 8 weeks ]compare anxiety symptoms between the two group using the Generalized Anxiety Disorder (GAD-7)
- Quality of life using the Functional Assessment of Cancer Therapy (FACT-G) [ Time Frame: up to 8 weeks ]to compare quality of life between the two groups using the Functional Assessment of Cancer Therapy -General (FACT-G)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02069743
|United States, Massachusetts|
|The Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Kamal Jethwani, MD, MPH||Massachusetts General Hospital|